Amy Peterson
2020 - CytomX Therapeutics
In 2020, Amy Peterson earned a total compensation of $899.4K as President, Chief Operating Officer at CytomX Therapeutics, a 74% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $301,800 |
|---|---|
| Option Awards | $94,643 |
| Salary | $503,000 |
| Total | $899,442 |
Peterson received $503K in salary, accounting for 56% of the total pay in 2020.
Peterson also received $301.8K in non-equity incentive plan and $94.6K in option awards.
Rankings
In 2020, Amy Peterson's compensation ranked 9,059th out of 13,090 executives tracked by ExecPay. In other words, Peterson earned more than 30.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,059 out of 13,090 | 31st |
Division Manufacturing | 3,873 out of 5,624 | 31st |
Major group Chemicals And Allied Products | 1,568 out of 2,257 | 31st |
Industry group Drugs | 1,371 out of 1,957 | 30th |
Industry Pharmaceutical Preparations | 1,014 out of 1,462 | 31st |
Source: SEC filing on April 27, 2022.
Peterson's colleagues
We found four more compensation records of executives who worked with Amy Peterson at CytomX Therapeutics in 2020.
News
CytomX Therapeutics CEO Sean McCarthy's 2022 pay falls 31% to $3M
April 27, 2023
CytomX Therapeutics CEO Sean McCarthy's 2021 pay jumps 52% to $4.3M
April 27, 2022
BeiGene, Ltd. CEO John Oyler's 2019 pay falls 55% to $13M
April 28, 2020
BeiGene, Ltd. CEO John Oyler's 2018 pay jumps 171% to $28M
April 29, 2019